World-class diagnostics for low-income communities in sub-Saharan Africa
MDaaS Global works to transform health care in Africa by bringing high-end medical diagnostics to low-income communities.
MDaaS Global works to transform health care in Africa by bringing high-end medical diagnostics to low-income communities.
Two drugs that block cell division synergize to kill tumor cells.
Recent graduate says culturally-aware approaches lead to more-effective medical interventions.
System lets nonspecialists use machine-learning models to make predictions for medical research, sales, and more.
Attaching a Velcro-like molecule may prevent immune proteins called cytokines from leaking out of cancerous tissue after injection.
Interacting with a robotic teddy bear invented at MIT boosted young patients’ positive emotions, engagement, and activity level.
Crystallized drug prevents immune system rejection of transplanted pancreatic islet cells.
Study may be a step toward shelf-stable versions of the hormone, which is used to control diabetes.
Novel materials made with FDA-approved components could deliver large payloads of active ingredients.
System helps machine-learning models glean training information for diagnosing and treating brain conditions.
Compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.
Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.
Through computing, senior and Marshall Scholar Anna Sappington seeks answers to biological questions.
A study of prostate cancer finds “aneuploid” tumors are more likely to be lethal than tumors with normal chromosome numbers.
Researchers apply network theory to HIV protein structure, uncovering a vital link between connectivity and protective immune response.